Seattle Startup Chases Alzheimer’s with Series A
Seattle-based AltPep Corporation raised $23.15 million in a Series A financing round to take the company’s breakthrough amyloid targeting platform to development.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
Biden’s federal boost to vaccine rollout is critical to speeding inoculations
/in Coronavirus, COVID-19 inoculations, COVID-19 Vaccinations, Covid-19 Variant, Epidemics, Joe Biden, U.S. Health Secretary Alex Azar, United StatesPresident-elect Joe Biden’s plan to boost the Covid-19 vaccine rollout – including by spending $20 billion to create mass vaccination centers – should help speed up putting shots into the arms of millions of Americans, experts and officials told Reuters.
Final Highlights from 2021 J.P. Morgan Healthcare Conference
/in Biologics License Application (BLA), Biomarkers, Blockbusters, Checkpoint Inhibitors, Clinical Trial Endpoints, Clinical Trials, Covid-19 Data, J.P. Morgan Healthcare Conference, Lung Cancer, Ovarian Cancer, R&D, Solid Tumors, TherapeuticsAs the 2021 virtual J.P. Morgan Healthcare Conference wrapped up, BioSpace reviewed news from companies regarding their deals, pipeline and regulatory updates.
FDA Approves Pfizer’s Xalkori for Rare Form of Pediatric Non-Hodgkin Lymphoma
/in Blockbusters, naplastic Large Cell Lymphoma (ALCL), Non-Hodgkin Lymphoma, Pediatric Cancer, Pfizer, Relapsed or refractory ALK-positive ALCL, Therapeutics, Tyrosine kinase inhibitorsThe U.S. Food and Drug Administration approved Pfizer’s Xalkori (crizotinib) for pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma that is anaplastic lymphoma kinase-positive.
Pfizer temporarily reduces Covid vaccine deliveries to Europe
/in Business, COVID-19 Doses, COVID-19 vaccine rollout, Europe, Norway, PfizerPfizer will temporarily reduce deliveries to Europe of the company’s vaccine against Covid-19 while upgrading production capacity.
AstraZeneca lung cancer drug gets nod for new dosing regimen in EU, UK
/in Advanced Non-Small Cell Lung Cancer, Approvals, AstraZeneca, Blockbusters, COVID-19 Crisis, Dosing, European Commission, European Union, PD-1/PD-L1 inhibitors, Therapeutics, United KingdomAstraZeneca Plc’s cancer drug Imfinzi was approved in Europe and Britain for a spaced-out regimen in a common type of lung cancer to help reduce the frequency of hospital visits while continuing treatment.
Shark Tank’s Mark Cuban Dives into Generic Drug Market
/in Business, Dallas, Drug Pricing, Generics, Medications, Pharmacies, Start-UpsBillionaire entrepreneur Mark Cuban – best known as the owner of the Dallas Mavericks and an investor on the ABC business reality series “Shark Tank” – is diving into generic drugs with a new startup, dubbed Mark Cuban Cost Plus Drug Company.
CLOSERLOOK ELEVATES DAVID DROLL TO MANAGING DIRECTOR AND CHELSEA PATTON TO GROUP ACCOUNT DIRECTOR
/in Appointments, Digital Marketing, Healthcare Communications Agencies, Marketing & Advertising, People on the Move, Promotionscloserlook inc. promoted two members of the digital-native marketing agency’s account team: David Droll and Chelsea Patton.
Mapping the Future of the Covid-19 Pandemic
/in SARS-CoV-2 virusA drop-off in virulence is possible for the SARS-CoV-2 virus – once enough of the global population has been vaccinated or exposed to it, according to a study from scientists at Emory University and The Pennsylvania State University.
Pfizer Growth Initiative Invests $120 Million into Four Companies
/in PfizerThe Pfizer Breakthrough Growth Initiative has invested a total of $120 million into four separate clinical-stage biotech companies.